Steps towards an international classification system for cancer pain

Size: px
Start display at page:

Download "Steps towards an international classification system for cancer pain"

Transcription

1 1 EPCRC Steps towards an international classification system for cancer pain Stein Kaasa Ghent, 18 October, 2012 Cancer Clinic St. Olavs University Hospital, Trondheim, Norway

2 Background 2 Pain

3 Background: 3 Cancer pain Pain in cancer patients About 70% of cancer patients with advanced disease experience pain As many as 50 % are undertreated Teunissen et al. J. Pain Symptom Manage Holtan et al. Palliat Med 2007

4 Background: 4 Cancer pain The lack of standardised diagnostic tools is one reason for the undertreatment of cancer pain Bruera et al. Pain 1989 Fainsinger et al. Eur. J. Cancer 2008 Harding et al. J Pain Symptom Manage 2011

5 Background: 5 Classification Classification

6 Background: 6 Classification Classification what is it? To make a diagnosis is to classify To classify means to arrange groups of conditions The grouping is based upon predefined criteria Hempel 1961 Hjermstad et al. Curr. Opin. Support.Palliat. Care 2009

7 Background: 7 Assessment Assessment constitutes the basis for correct classification Measurement: Process of collecting and documenting information needed to conclude For subjective symptoms the gold-standard is patients self-report Hjermstad et al. Curr. Opin. Support.Palliat. Care 2009 Fayers PM, Machin D, editors. Quality of Life. The assessment, analysis and interpretation of patient-reported outcomes 2007

8 Background: 8 Assessment Numerical rating scale 0-10 (NRS-11) Body map

9 9 Commonly used terms in this presentation Symptom Cancer pain Domains Pain intensity Pain localisation Items NRS-11 Body map

10 Background. 10 Classification Classification systems in medicine International Classification of Diseases (ICD-10) Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) TNM (Tumour Node Metastasis) Classification of Malignant Tumors

11 Background 11 : Cancer pain classification Cancer pain classification For cancer pain, there is no international classification system that is widely used Caraceni et al. Oncology 2001 Fainsinger et al. Eur. J. Cancer 2010 Kaasa et al. BMJ Support. Palliat. Care 2011

12 Background: 12 EPCRC International collaboration needed European Palliative Care Research Collaborative EPCRC Among the aims: To improve treatment To develop an international, computer based assessment and classification system for pain, depression and cachexia in cancer patients

13 Background: 13 EPCRC Step wise research strategy of the EPCRC Assessment and classification system for cancer pain Empirical data Patients opinions Experts opinions Literature review Kaasa et al. J Clin Oncol 2008

14 14 Systematic literature review

15 15

16 Systematic 16 literature review Aim To identify existing approaches to cancer pain classification

17 Systematic 17 literature review Methods Systematic literature review Databases: MEDLINE and Embase English papers, adults Search terms: Pain Neoplasm / cancer Classification/categorisation/characterisation/grading/staging Screening of titles and abstract by four authors Reviewing of full-text papers by three authors

18 Systematic 18 literature review Results 692 hits -> 92 full-text papers (55 clinical studies) International Association for the Study of Pain Classification of Chronic Pain 1 Edmonton Classification System for Cancer Pain 2 Cancer Pain Prognostic Scale 3 Opioid Escalation Index 4 Prognostic tool for pain treatment 5 Pain Management Index 6 1.Merskey Fainsinger et al. Eur. J. Cancer Hwang et al. J. Pain Symptom Manage Mercadante et al. J. Pain Symptom Manage Mercadante et al. Pain Cleeland et al. N. Engl. J. Med. 1994

19 Systematic 19 literature review Results continued None of the systems are widely applied Domains identified in two or more of the systems: Pain intensity Breakthrough pain Pain mechanism Psychological distress Treatment response Assessment methods used varied across studies

20 20 Patients opinions

21 Patients 21 opinions

22 Patients 22 opinions Aims To investigate if the patients could verify the relevance of previously identifed pain domains To explore if domains were missing To gain in-depth understanding of pain domains

23 Patients 23 opinions Methods Qualitative study using semi-structured interviews with advanced cancer patients on opioids Quantitative part: Patients scoring of the importance of 12 domains relevant for cancer pain classification on an NRS-11

24 Patients 24 opinions Patients N = 33 Age (mean) 63 Male (n) 17 Female (n) 16 Karnofsky Performance Status (mean) 65 Gastro intestinal cancer (n) 11 Lung cancer (n) 8 Breast cancer (n) 4 Urological cancer (n) 8 Opioid dose (MEDD) mg (mean) 139

25 Patients 25 opinions Results Previously identified domains were confirmed to be relevant to the patients Poorer emotional and physical functioning were domains emphasised by the patients Sleep disturbances were important to the patients

26 Patients 26 opinions Results continued Ranking of domains importance by the patients 1. Etiology 2. Duration of pain 3. Pain intensity 4. Coping 5. Localisation of pain 6. Physical functioning 7. Psychological distress 8. Breakthrough pain 9. Congitive function 10. Neuropathic pain 11. Previous pain experience 12. Addiction

27 27 Experts opinions

28 Experts 28 opinions

29 Experts 29 opinions Aim To gain information on the most important/ relevant domains and items for a computerised pain assessment tool

30 Experts 30 opinions Methods Clinical / research experts (EPCRC, EAPC, IASP, WHO) N = 32, response rate = 72% Relevance rating of the previously ranked pain domains on an NRS-11

31 Experts 31 opinions Results and comparison Domain Patients ranking Experts ranking Etiology 1 - Duration 2 7 Intensity 3 1 Coping 4 10 Localisation 5 5 Physical functioning 6 6 Psychological distress 7 8 Breakthrough pain 8 2 Cognitive function 9 - Pain mechanism 10 4 Previous pain experience 11 9 Addiction 12 - Treatment, exacerbating - 3 and relieving factors

32 32 Empirical data I

33 Empirical 33 data EPOS

34 Empirical 34 data EPOS Aims To verify the relevance of domains identified in previous studies To explore new domains

35 Empirical 35 data EPOS European Pharmacogenetic Opioid Study (EPOS) Cross-sectional 11 European countries, 17 centres 2278 cancer patients on opioids evaluable Klepstad et al. Pain 2011

36 Empirical 36 data EPOS Patients EPOS N = 2278 Age (mean) 62 Male % 52.4 Female % 47.6 Karnofsky Performance Status (mean) 59 Gastro intestinal cancer % 23 Lung cancer % 18 Breast cancer % 13 Prostate cancer % 12 Pain intensity on the average (mean) 3.5 Pain intensity at its worst (mean) 5.25 Pain relief (mean) 74 Breakthrough pain % 58 Mixed pain % 34.2 Neuropathic pain % 4.8 Patients on opioids % 100 Opioid dose (MEDD) mg (mean) 341

37 Empirical 37 data EPOS Methods 46 independent domains/items were included based upon findings from previous studies Outcomes: Pain on average Pain at its worst Pain relief Bivariate correlation analysis Multivariate regression analysis with 21 domains/items

38 Empirical 38 data EPOS Results Breakthrough pain Psychological distress Pain mechanism Localisation of pain Opioid dose Use of non-opioids Sleep Addiction Cancer diagnosis Localisation of metastases R 2 = 12%-19%

39 39 Empirical data II

40 Empirical 40 data - CPOR

41 Empirical 41 data - CPOR Aims To confirm results from EPOS in an independent patient population To identify cancer pain predictors in a longitudinal study

42 Empirical 42 data - CPOR Cancer Pain Outcome Research (CPOR) Study Group Longitudinal 110 Italian centres 1801 cancer patients with pain Apolone et al. Br. J. Cancer 2009

43 Empirical 43 data - CPOR Methods - analysis of cross-sectional data Outcomes: Pain on average Pain at its worst Pain relief Multivariate regression analysis with the results from paper III as independent domains/items

44 Empirical 44 data - CPOR Methods analysis of longitudinal data 45 independent domains/items were included based upon findings from previous studies Outcomes on day 14: Pain on average Pain at its worst Pain relief Bivariate correlation analysis Multivariate regression analysis with 20 domains/items

45 Empirical 45 data - CPOR Results patients at study entry Sample A Crosssectional analysis N= 1529 Age (mean) Male % Female % Karnofsky Performance Status (mean) Gastro intestinal cancer % Lung cancer % Breast cancer % 17 9 Prostate cancer % 8 6 Pain intensity on the average (mean) Pain intensity at its worst (mean) Pain relief (mean) Breakthrough pain % Neuropathic pain % Patients on opioids % Opioid dose (MEDD) mg (mean) Sample B Longitudinal analysis N =352

46 Empirical 46 data - CPOR Results from cross-sectional data Breakthrough pain Localisation of pain Opioids Non-opioids Sleep R 2 = 21%-26%

47 Empirical 47 data - CPOR Results from longitudinal data Pain intensity at study entry Pain relief at study entry Breakthrough pain Localisation of pain Age Cancer diagnosis R 2 = 16%-24%

48 48 Conclusions

49 Conclusions 49 Conclusions from five EPCRC-publications There is no widely used international classification system for cancer pain Several aspects need to be considered when classifying cancer pain Pain domains Other subjective symptoms Patient s demographics Cancer disease

50 Conclusions 50 Identified domains relevant for cancer pain classification Pain intensity Pain relief Breakthrough pain Localisation of pain Neuropathic pain Opioids Psychological distress Non-opioids Sleep Addiction Cancer diagnosis Age Explained variance = 12% to 26 % Kaasa et al. BMJ Support Palliat Care 2011

51 Future 51 perspectives How do we proceed?

52 Future 52 perspectives Future perspectives What information can increase the explained variance? Agreement on domains to include and assessment methods to use is needed Prospective intervention studies are needed Continued international collaboration is needed

53 Future 53 perspectives Future perspectives continued An assessment and classification system needs to be combined with clinical treatment guidelines Implementation into clincal practice could be facilitated by information technology and clinical decision support systems

54 54 Acknowledgements The European Palliative Care Research Collaborative The European Palliative Care Research Centre The patients participating in the studies All researchers involved in the EPOS and CPOR studies All co-authors and contributors

55 55 EPCRC Thank you for your attention

Moving on - the next step in developing an International Classification System for Cancer Pain

Moving on - the next step in developing an International Classification System for Cancer Pain Robin Fainsinger, Cheryl Nekolaichuk, Pablo Amigo, Amanda Brisebois, Sarah Burton Macleod, Rebekah Gilbert, Yoko Tarumi, Vincent Thai, Gary Wolch, Lara Fainsinger & Viki Muller Division of Palliative Care

More information

Cancer Pain Assessment and Classification

Cancer Pain Assessment and Classification Cancer Pain Assessment and Classification Peter Lawlor Elisabeth Bruyère & University of Ottawa 4/06/2012 EAPC Preconf Plenary 1 Goals of systematic cancer pain assessment and classification Clinical care

More information

Moving on useful clinical lessons learned in developing an International Classification System for Cancer Pain

Moving on useful clinical lessons learned in developing an International Classification System for Cancer Pain Robin Fainsinger, Cheryl Nekolaichuk. Division of Palliative Care Medicine, University of Alberta, and Covenant Health Palliative Institute, Edmonton, Canada Moving on useful clinical lessons learned in

More information

ABSTRACT ORIGINAL RESEARCH. Erik Torbjørn Løhre. Marianne Jensen Hjermstad. Cinzia Brunelli. Anne Kari Knudsen. Stein Kaasa.

ABSTRACT ORIGINAL RESEARCH. Erik Torbjørn Løhre. Marianne Jensen Hjermstad. Cinzia Brunelli. Anne Kari Knudsen. Stein Kaasa. Pain Ther (2018) 7:193 203 https://doi.org/10.1007/s40122-018-0107-8 ORIGINAL RESEARCH Pain Intensity Factors Changing Breakthrough Pain Prevalence in Patients with Advanced Cancer: A Secondary Analysis

More information

Moving on - the next step in developing an International Classification System for Cancer Pain

Moving on - the next step in developing an International Classification System for Cancer Pain Robin Fainsinger, Cheryl Nekolaichuk, Pablo Amigo, Amanda Brisebois, Sarah Burton Macleod, Rebekah Gilbert, Yoko Tarumi, Vincent Thai, Gary Wolch, Lara Fainsinger & Viki Muller Division of Palliative Care

More information

White Rose Research Online URL for this paper: Version: Accepted Version

White Rose Research Online URL for this paper:  Version: Accepted Version This is a repository copy of From "Breakthrough" to "Episodic" Cancer Pain? A European Association for Palliative Care Research Network Expert Delphi Survey Towards a Common Terminology and Classification

More information

PRAIS Two perspectives. Current cancer pain research 12/4/2015. More complex thinking in cancer pain studies. Usual thinking in cancer pain studies

PRAIS Two perspectives. Current cancer pain research 12/4/2015. More complex thinking in cancer pain studies. Usual thinking in cancer pain studies PRC European Palliative Care Research Centre PRAIS The Palliative Radiotherapy And Study PRAIS Two perspectives Predict response from radiotherapy given for bone cancer Pål Klepstad Dept. Intensive Care

More information

Development of a computerized tool for self-assessment of subjective symptoms that can be integrated in a Personal health record

Development of a computerized tool for self-assessment of subjective symptoms that can be integrated in a Personal health record Development of a computerized tool for self-assessment of subjective symptoms that can be integrated in a Personal health record Frode Laugen 1 1 Dept of cancer research and molecular medicine, Faculty

More information

WS2 EVIDENCE IN PAIN THERAPY FROM A SOCIETAL PERSPECTIVE PAIN UNDERTREATMENT IN ONCOLOGICAL PATIENTS

WS2 EVIDENCE IN PAIN THERAPY FROM A SOCIETAL PERSPECTIVE PAIN UNDERTREATMENT IN ONCOLOGICAL PATIENTS WS2 EVIDENCE IN PAIN THERAPY FROM A SOCIETAL PERSPECTIVE PAIN UNDERTREATMENT IN ONCOLOGICAL PATIENTS CERP CENTER FOR THE RESEARCH & EVALUATION OF CANCER Giovanni Apolone BACKGROUND PAIN AFFLICTS MOST OF

More information

Improving quality of care for cancer pain. pain: an Italian five-year project

Improving quality of care for cancer pain. pain: an Italian five-year project Improving quality of care for cancer pain: an Italian five-year project Maria Teresa Greco (1,2), Anna Roberto (3), Oscar Corli (2), Giovanni (4) Background: cancer pain is still undertreated as for inappropriate

More information

Integration of palliative care into oncology

Integration of palliative care into oncology 1 Integration of palliative care into oncology Stein Kaasa European Palliative Care Research Centre, Faculty of Medicine, NTNU and Department of Oncology, St. Olavs Hospital, Trondheim University Hospital

More information

Impact of Palliative Care Unit Admission on Symptom Control Evaluated by the Edmonton Symptom Assessment System

Impact of Palliative Care Unit Admission on Symptom Control Evaluated by the Edmonton Symptom Assessment System Vol. 30 No. 4 October 2005 Journal of Pain and Symptom Management 367 Original Article Impact of Palliative Care Unit Admission on Symptom Control Evaluated by the Edmonton Symptom Assessment System Caterina

More information

Changes Over Time in Occurrence, Severity, and Distress of Common Symptoms During and After Radiation Therapy for Breast Cancer

Changes Over Time in Occurrence, Severity, and Distress of Common Symptoms During and After Radiation Therapy for Breast Cancer 98 Journal of Pain and Symptom Management Vol. 45 No. June Original Article Changes Over Time in Occurrence, Severity, and Distress of Common Symptoms During and After Radiation Therapy for Breast Cancer

More information

THE EAPC OPIOID GUIDELINES: PROCESS, RESULTS AND FUTURE DEVELOPMENT

THE EAPC OPIOID GUIDELINES: PROCESS, RESULTS AND FUTURE DEVELOPMENT 1 THE EAPC OPIOID GUIDELINES: PROCESS, RESULTS AND FUTURE DEVELOPMENT Jaegtvolden 4-5 June 2012 14. 12. 2012 2 1 3 WHO ANALGESIC LADDER (1996) NSAID +/- Adjuvant STEP II OPIODS Opids for mild to moderate

More information

Multidimensional fatigue and its correlates in hospitalized advanced cancer patients

Multidimensional fatigue and its correlates in hospitalized advanced cancer patients Chapter 5 Multidimensional fatigue and its correlates in hospitalized advanced cancer patients Michael Echtelda,b Saskia Teunissenc Jan Passchierb Susanne Claessena, Ronald de Wita Karin van der Rijta

More information

Impact of pre-treatment symptoms on survival after palliative radiotherapy An improved model to predict prognosis?

Impact of pre-treatment symptoms on survival after palliative radiotherapy An improved model to predict prognosis? Impact of pre-treatment symptoms on survival after palliative radiotherapy An improved model to predict prognosis? Thomas André Ankill Kämpe 30.05.2016 MED 3950,-5 year thesis Profesjonsstudiet i medisin

More information

Programme overview (subject to change)

Programme overview (subject to change) Programme overview (subject to change) Time 0800-0900 Premiminary programme - Thursday 7 June Olavshallen 1204 seats Olav Tryggvasson 325 seats Haraldsalen 140 seats Tavern/ Brattøra 210 seats 0900-1100

More information

Predictors of Quality of Life in Oncology Outpatients with Pain from Bone Metastasis

Predictors of Quality of Life in Oncology Outpatients with Pain from Bone Metastasis 234 Journal of Pain and Symptom Management Vol. 30 No. 3 September 2005 Original Article Predictors of Quality of Life in Oncology Outpatients with Pain from Bone Metastasis Tone Rustøen, RN, PhD, Torbjørn

More information

Depression in Cancer EAPC Glasgow 2010

Depression in Cancer EAPC Glasgow 2010 Marie Fallon St Columba s Hospice Chair of Palliative Medicine University of Edinburgh Depression in Cancer EAPC Glasgow 2010 Are cancer pain and depression interdependent? Laird BJA, Boyd AC, Colvin

More information

Complicated pain. Dr Stephanie Lippett

Complicated pain. Dr Stephanie Lippett Complicated pain Dr Stephanie Lippett UK incidence & prevalence of cancer pain 1% of UK population are living with cancer at present 70% of cancer patients experience pain 70-90% of patients with advanced

More information

Initial assessment of patients without cognitive failure admitted to palliative care: a validation study

Initial assessment of patients without cognitive failure admitted to palliative care: a validation study Original Article Initial assessment of patients without cognitive failure admitted to palliative care: a validation study José António Ferraz Gonçalves 1, Clara Castro 2, Paula Silva 1, Rui Carneiro 1,

More information

The detection and management of pain in patients with dementia in acute care settings: development of a decision tool: Research protocol.

The detection and management of pain in patients with dementia in acute care settings: development of a decision tool: Research protocol. The detection and management of pain in patients with dementia in acute care settings: development of a decision tool: Research protocol. Aims and Objectives of the overall study The aim of this study

More information

Radiotherapy symptoms control in bone mets. Francesco Cellini GemelliART. Ernesto Maranzano,MD. Session 5: Symptoms management

Radiotherapy symptoms control in bone mets. Francesco Cellini GemelliART. Ernesto Maranzano,MD. Session 5: Symptoms management Session 5: Symptoms management Radiotherapy symptoms control in bone mets Francesco Cellini GemelliART Ernesto Maranzano,MD Director of Oncology Department Chief of Radiation Oncology Centre S. Maria Hospital

More information

Interprofessional Webinar Series

Interprofessional Webinar Series Interprofessional Webinar Series Opioids in the Medically Ill: Principles of Administration Russell K. Portenoy, MD Chief Medical Officer MJHS Hospice and Palliative Care Director MJHS Institute for Innovation

More information

Time to Pain Relief After Immediate-Release Morphine in Episodic Pain The TIME Study

Time to Pain Relief After Immediate-Release Morphine in Episodic Pain The TIME Study ORIGINAL RESEARCH ARTICLE Clin Drug Investig 21; 3 Suppl. 2: 49-55 1173-2563/1/2-49/$49.95/ ª 21 Adis Data Information BV. All rights reserved. Time to Pain Relief After Immediate-Release Morphine in Episodic

More information

Quality of Life Instrument - Breast Cancer Patient Version

Quality of Life Instrument - Breast Cancer Patient Version NATIONAL MEDICAL CENTER AND BECKMAN RESEARCH INSTITUTE Dear Colleague: Quality of Life Instrument - Breast Cancer Patient Version The Quality of Life Instrument (BREAST CANCER PATIENT VERSION) is a forty-six

More information

Multidimensional Measurement of Fatigue in Advanced Cancer Patients in Palliative Care: An Application of the Multidimensional Fatigue Inventory

Multidimensional Measurement of Fatigue in Advanced Cancer Patients in Palliative Care: An Application of the Multidimensional Fatigue Inventory Vol. 31 No. 6 June 2006 Journal of Pain and Symptom Management 533 Original Article Multidimensional Measurement of Fatigue in Advanced Cancer Patients in Palliative Care: An Application of the Multidimensional

More information

Cancer-related pain has become a major problem worldwide.

Cancer-related pain has become a major problem worldwide. global perspectives on CAnCer pain issues in Africa Olaitan Soyannwo MBBS MMed Cancer-related pain has become a major problem worldwide. Pain can be caused by cancer, cancer treatment or by the side effects

More information

Blending Perspectives and Bridging Differences: Weaving Clinical Research into Whole Person Care

Blending Perspectives and Bridging Differences: Weaving Clinical Research into Whole Person Care Blending Perspectives and Bridging Differences: Weaving Clinical Research into Whole Person Care Dr. Cheryl Nekolaichuk Division of Palliative Care Medicine, University of Alberta Edmonton Palliative Care

More information

Development of a Cancer Pain Prognostic Scale

Development of a Cancer Pain Prognostic Scale 366 Journal of Pain and Symptom Management Vol. 24 No. 4 October 2002 Original Article Development of a Cancer Pain Prognostic Scale Shirley S. Hwang, RN, MS, AOCN, Victor T. Chang, MD, Diane L. Fairclough,

More information

Prognostic Factors of Survival in Patients With Advanced Cancer Admitted to Home Care

Prognostic Factors of Survival in Patients With Advanced Cancer Admitted to Home Care 56 Journal of Pain and Symptom Management Vol. 45 No. 1 January 2013 Original Article Prognostic Factors of Survival in Patients With Advanced Cancer Admitted to Home Care Sebastiano Mercadante, MD, Alessandro

More information

MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER

MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER (Text update March 2008) A. Stenzl (chairman), N.C. Cowan, M. De Santis, G. Jakse, M. Kuczyk, A.S. Merseburger, M.J. Ribal, A. Sherif, J.A. Witjes Introduction

More information

CHOOSING WISELY CANADA DE-IMPLEMENTING LOW VALUE CARE

CHOOSING WISELY CANADA DE-IMPLEMENTING LOW VALUE CARE CHOOSING WISELY CANADA DE-IMPLEMENTING LOW VALUE CARE JANET E. SQUIRES RN, PhD CENTRE FOR IMPLEMENTATION RESEARCH LAUNCH JANUARY 19 TH, 2018 www.ohri.ca PRESENTATION OUTLINE The problem of low value care

More information

Feng-Yi Lai, RN, MSN, Instructor Department of Nursing, Shu-Zen College of Medicine and Management, Asphodel Yang, RN, PhD, Associate Professor

Feng-Yi Lai, RN, MSN, Instructor Department of Nursing, Shu-Zen College of Medicine and Management, Asphodel Yang, RN, PhD, Associate Professor Feng-Yi Lai, RN, MSN, Instructor Department of Nursing, Shu-Zen College of Medicine and Management, Asphodel Yang, RN, PhD, Associate Professor Department of Nursing, Central Taiwan University of Science

More information

Clinical Evidence. A BMJ database of the very best evidence for effective health care

Clinical Evidence. A BMJ database of the very best evidence for effective health care Clinical Evidence A BMJ database of the very best evidence for effective health care Myleen Oosthuizen Academic Information Service School for Health Sciences What is Clinical Evidence? An international

More information

Dr Barry Laird Clinician Scientist in Palliative Medicine University of Edinburgh and the European Palliative Care Research Centre (PRC)

Dr Barry Laird Clinician Scientist in Palliative Medicine University of Edinburgh and the European Palliative Care Research Centre (PRC) 1 Dr Barry Laird Clinician Scientist in Palliative Medicine University of Edinburgh and the European Palliative Care Research Centre (PRC) 2 Acknowledgements Prof Marie Fallon (group lead EPAS) University

More information

Perigastric lymph node metastases in gastric cancer: comparison of different staging systems

Perigastric lymph node metastases in gastric cancer: comparison of different staging systems Gastric Cancer (1999) 2: 201 205 Original article 1999 by International and Japanese Gastric Cancer Associations Perigastric lymph node metastases in gastric cancer: comparison of different staging systems

More information

Pharmacologic and Nonpharmacologic Interventions for Pain

Pharmacologic and Nonpharmacologic Interventions for Pain PUTTING EVIDENCE INTO PRACTICE: IMPROVING ONCOLOGY PATIENT OUTCOMES Pharmacologic and Nonpharmacologic Interventions for Pain Introduction A variety of treatments such as chemotherapy, radiation therapy,

More information

What is cancer breakthrough pain?

What is cancer breakthrough pain? Chapter 2 What is cancer breakthrough pain? Definitions The original definition of cancer breakthrough pain (cbtp), given by Portenoy and Hagen [1], is the template upon which the majority of subsequent

More information

A Personalized Approach to Assessing and Managing Pain in Patients With Cancer David Hui and Eduardo Bruera

A Personalized Approach to Assessing and Managing Pain in Patients With Cancer David Hui and Eduardo Bruera VOLUME 32 NUMBER 16 JUNE 1 2014 JOURNAL OF CLINICAL ONCOLOGY R E V I E W A R T I C L E A Personalized Approach to Assessing and Managing Pain in Patients With Cancer David Hui and Eduardo Bruera All authors:

More information

An Improved Digital Pain Body Map

An Improved Digital Pain Body Map An Improved Digital Pain Body Map Ellen Anna Andreassen Jaatun, Dagny Faksvåg Haugen, Yngve Dahl, Anders Kofod-Petersen European Palliative Care Research Centre, Norwegian University of Science and Technology

More information

Management of Cancer Symptoms: Pain, Depression, and Fatigue

Management of Cancer Symptoms: Pain, Depression, and Fatigue Agency for Healthcare Research and Quality Evidence Report/Technology Assessment Number 61 Management of Cancer Symptoms: Pain, Depression, and Fatigue Summary Overview This evidence report on Management

More information

Low Morphine Doses in Opioid-Naive Cancer Patients with Pain

Low Morphine Doses in Opioid-Naive Cancer Patients with Pain 242 Journal of Pain and Symptom Management Vol. 31 No. 3 March 2006 Original Article Low Morphine Doses in Opioid-Naive Cancer Patients with Pain Sebastiano Mercadante, MD, Gianpiero Porzio, MD, Patrizia

More information

Opioid Escalation in Patients with Cancer Pain: The Effect of Age

Opioid Escalation in Patients with Cancer Pain: The Effect of Age Vol. 32 No. 5 November 2006 Journal of Pain and Symptom Management 413 Original Article Opioid Escalation in Patients with Cancer Pain: The Effect of Age Sebastiano Mercadante, MD, Patrizia Ferrera, MD,

More information

Symptom Assessment in Palliative Care

Symptom Assessment in Palliative Care Symptom Assessment in Palliative Care Maria Nabal www.arnau.scs.es Sumary SYMPTOM ASSESSMENT Is it really necessary? What for? Which symptoms? How to conduct the assessment? Is there any other area of

More information

Watching and waiting : what it means for patients. Dr Christian Aldridge Consultant Dermatologist Cwm Taf NHS Trust

Watching and waiting : what it means for patients. Dr Christian Aldridge Consultant Dermatologist Cwm Taf NHS Trust Watching and waiting : what it means for patients Dr Christian Aldridge Consultant Dermatologist Cwm Taf NHS Trust Watching and waiting or...watching and worrying Once you have a cancer diagnosis, you

More information

Quality of Life at the End of Life:

Quality of Life at the End of Life: Quality of Life at the End of Life: Evaluating the Clinical Utility of the QUAL-EC in Patients with Advanced Cancer 13 th Australian Palliative Care Conference 2015 Melbourne, Australia October 1 st 4

More information

Current controversies in the assessment and management of breakthrough cancer pain

Current controversies in the assessment and management of breakthrough cancer pain Review issue Andrew Davies Consultant in Palliative Medicine, Royal Surrey County Hospital Current controversies in the assessment and management of breakthrough cancer pain Abstract Breakthrough cancer

More information

TITLE SECOND LINE SPEAKER

TITLE SECOND LINE SPEAKER WENNBERG INTERNATIONAL COLLABORATIVE SPRING POLICY MEETING 2018 Inter-regional Variation In Opioid Prescription Patterns In Emilia-romagna And Tuscany TITLE STYLE MARIA PIA FANTINI, DARIO TEDESCO, BRUNA

More information

Dr Sylvie Lambert, RN, PhD

Dr Sylvie Lambert, RN, PhD Is it the most frequent unmet supportive care needs that predict caregivers anxiety and depression? Results from Australia s Partners and Caregivers Longitudinal Well-being Study Dr Sylvie Lambert, RN,

More information

Comparison of respiratory health-related quality of life in patients with intractable breathlessness due to advanced cancer or advanced COPD

Comparison of respiratory health-related quality of life in patients with intractable breathlessness due to advanced cancer or advanced COPD Comparison of respiratory health-related quality of life in patients with intractable breathlessness due to advanced cancer or advanced COPD Shagayegh Javadzadeh, BA (Hons) Cantab University of School

More information

Depression - a major contributor to poor quality of life in patients with advanced cancer

Depression - a major contributor to poor quality of life in patients with advanced cancer 1 Depression - a major contributor to poor quality of life in patients with advanced cancer Authors: Grotmol, K. S. (PhD) 1 *, Lie, H. C. (PhD) 2,3,4 *, Hjermstad, M. J. (PhD) 1,5, Aass, N. (PhD) 6,8,

More information

Author's response to reviews

Author's response to reviews Author's response to reviews Title: Validation of Doloplus-2 among nonverbal nursing home patients - An evaluation of Doloplus-2 in a clinical setting An evaluating of Doloplus-2 in a clinical setting

More information

CANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES California Cancer Reporting System Standards, Volume I

CANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES California Cancer Reporting System Standards, Volume I CANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES California Cancer Reporting System Standards, Volume I Changes and Clarifications 16 th Edition April 15, 2016 Quick Look- Updates to Volume

More information

Palliative Care in Patients with Brain Tumors: How to maintain hope and quality of life, even when treatments fail

Palliative Care in Patients with Brain Tumors: How to maintain hope and quality of life, even when treatments fail Tobias Walbert MD PhD MPH Assistant Professor Neurology Wayne State University Henry Ford Hospital Detroit twalber1@hfhs.org Palliative Care in Patients with Brain Tumors: How to maintain hope and quality

More information

Is there a genetic cause of appetite loss? an explorative study in 1,853 cancer patients

Is there a genetic cause of appetite loss? an explorative study in 1,853 cancer patients J Cachexia Sarcopenia Muscle (2012) 3:191 198 DOI 10.1007/s13539-012-0064-8 ORIGINAL ARTICLE Is there a genetic cause of appetite loss? an explorative study in 1,853 cancer patients Tora S. Solheim & Peter

More information

A Shared Symptom Burden Presents Opportunities for Collaboration between Outpatient Palliative Care and Psycho-Oncology Providers

A Shared Symptom Burden Presents Opportunities for Collaboration between Outpatient Palliative Care and Psycho-Oncology Providers A Shared Symptom Burden Presents Opportunities for Collaboration between Outpatient Palliative Care and Psycho-Oncology Providers NICOLE BATES, MD, PGY-IV PSYCHIATRY RESIDENT WESTERN PSYCHIATRIC INSTITUTE

More information

An Italian survey on the attitudes in treating breakthrough cancer pain in hospice

An Italian survey on the attitudes in treating breakthrough cancer pain in hospice Support Care Cancer (2011) 19:979 983 DOI 10.1007/s00520-010-0919-5 ORIGINAL ARTICLE An Italian survey on the attitudes in treating breakthrough cancer pain in hospice Sebastiano Mercadante & Patrizia

More information

Report to Waikato Medical Research Foundation

Report to Waikato Medical Research Foundation Report to Waikato Medical Research Foundation Understanding the importance of tumour biology and socio-demographic difference in cancer stage at diagnosis using the Midland Lung Cancer Register Ross Lawrenson

More information

Report on Cancer Statistics in Alberta. Breast Cancer

Report on Cancer Statistics in Alberta. Breast Cancer Report on Cancer Statistics in Alberta Breast Cancer November 2009 Surveillance - Cancer Bureau Health Promotion, Disease and Injury Prevention Report on Cancer Statistics in Alberta - 2 Purpose of the

More information

THE ISSUE OF STAGE AT DIAGNOSIS

THE ISSUE OF STAGE AT DIAGNOSIS THE ISSUE OF STAGE AT DIAGNOSIS IN SURVIVAL ANALYSIS Pamela Minicozzi Analytical Epidemiology and Health Impact Unit Department of Preventive and Predictive Medicine, Fodazione IRCCS Istituto Nazionale

More information

Palliative Sedation in Patients with Advanced Cancer Followed at Home: A Systematic Review

Palliative Sedation in Patients with Advanced Cancer Followed at Home: A Systematic Review 754 Journal of Pain and Symptom Management Vol. 41 No. 4 April 2011 Review Article Palliative Sedation in Patients with Advanced Cancer Followed at Home: A Systematic Review Sebastiano Mercadante, MD,

More information

Breakthrough Cancer Pain: Ten Commandments

Breakthrough Cancer Pain: Ten Commandments VALUE IN HEALTH 19 (2016) 531 536 Available online at www.sciencedirect.com journal homepage: www.elsevier.com/locate/jval ISSUE HIGHLIGHTS Decision-Maker Commentary Breakthrough Cancer Pain: Ten Commandments

More information

National Horizon Scanning Centre. Ipilimumab (MDX-010) for unresectable stage III or IV metastatic melanoma - first or second line treatment

National Horizon Scanning Centre. Ipilimumab (MDX-010) for unresectable stage III or IV metastatic melanoma - first or second line treatment Ipilimumab (MDX-010) for unresectable stage III or IV metastatic melanoma - first or second line treatment April 2008 This technology summary is based on information available at the time of research and

More information

International concepts related to prehospital emergency treatment in terminally ill patients a prospective questionnaire-based study

International concepts related to prehospital emergency treatment in terminally ill patients a prospective questionnaire-based study International concepts related to prehospital emergency treatment in terminally ill patients a prospective questionnaire-based study EAPC Research Congress 09.-12.06.2010 Glasgow, Scotland Department of

More information

Opioid-induced or pain relief-reduced symptoms in advanced cancer patients?

Opioid-induced or pain relief-reduced symptoms in advanced cancer patients? European Journal of Pain 10 (2006) 153 159 www.europeanjournalpain.com Opioid-induced or pain relief-reduced symptoms in advanced cancer patients? Sebastiano Mercadante a,b, *, Patrizia Villari a, Patrizia

More information

Malignant Spinal cord Compression. Dr. Thiru Thirukkumaran Palliative Care Services - Northwest Tasmania

Malignant Spinal cord Compression. Dr. Thiru Thirukkumaran Palliative Care Services - Northwest Tasmania Malignant Spinal cord Compression Dr. Thiru Thirukkumaran Palliative Care Services - Northwest Tasmania Background Statistics of SCC -1 Incidence of SCC Vertebral body metastases 85 % Para-vertebral (Lymphoma)

More information

Patients and Relatives Perceptions About Intravenous and Subcutaneous Hydration

Patients and Relatives Perceptions About Intravenous and Subcutaneous Hydration 354 Journal of Pain and Symptom Management Vol. 30 No. 4 October 2005 Original Article Patients and Relatives Perceptions About Intravenous and Subcutaneous Hydration Sebastiano Mercadante, MD, Patrizia

More information

Positron emission tomography (PET and PET/CT) in recurrent colorectal cancer 1

Positron emission tomography (PET and PET/CT) in recurrent colorectal cancer 1 IQWiG Reports - Commission No. D06-01C Positron emission tomography (PET and PET/CT) in recurrent colorectal cancer 1 Executive Summary 1 Translation of the executive summary of the final report Positronenemissionstomographie

More information

Review on Tumour Doubling Time (DT) To review the studies that measuring the actual tumour doubling time for human cancers.

Review on Tumour Doubling Time (DT) To review the studies that measuring the actual tumour doubling time for human cancers. Review on Tumour Doubling Time (DT) Objective To review the studies that measuring the actual tumour doubling time for human cancers. Methods We searched the Medline database from January 1966 to January

More information

Cancer pain management in an oncological ward in a comprehensive cancer center with an established palliative care unit

Cancer pain management in an oncological ward in a comprehensive cancer center with an established palliative care unit Support Care Cancer (2013) 21:3287 3292 DOI 10.1007/s00520-013-1899-z ORIGINAL ARTICLE Cancer pain management in an oncological ward in a comprehensive cancer center with an established palliative care

More information

Health-related quality of life assessed before and during chemotherapy predicts for survival in multiple myeloma

Health-related quality of life assessed before and during chemotherapy predicts for survival in multiple myeloma British Journal of Haematology, 1997, 97, 29 37 Health-related quality of life assessed before and during chemotherapy predicts for survival in multiple myeloma FINN WISLØFF 1 AND MARTIN HJORTH 2 for the

More information

Integration of Palliative and Oncology Care in patients with lung and other

Integration of Palliative and Oncology Care in patients with lung and other 1 Integration of Palliative and Oncology Care in patients with lung and other thoracic cancer: referral criteria and clinical care pathways. A. Caraceni, C. Brunelli, S. Lo Dico, E. Zecca, P. Bracchi,

More information

1/3/2008. Karen Burke Priscilla LeMone Elaine Mohn-Brown. Medical-Surgical Nursing Care, 2e Karen Burke, Priscilla LeMone, and Elaine Mohn-Brown

1/3/2008. Karen Burke Priscilla LeMone Elaine Mohn-Brown. Medical-Surgical Nursing Care, 2e Karen Burke, Priscilla LeMone, and Elaine Mohn-Brown Medical-Surgical Nursing Care Second Edition Karen Burke Priscilla LeMone Elaine Mohn-Brown Chapter 12 Caring for Clients with Cancer Cancer Disease that results when normal cells mutate into abnormal,

More information

The Role of Personal and Social Resources and Coping For Finding Meaning in Cancer: A Longitudinal Study

The Role of Personal and Social Resources and Coping For Finding Meaning in Cancer: A Longitudinal Study Fachbereich Erziehungswissenschaft und Psychologie Der Freien Universität Berlin The Role of Personal and Social Resources and Coping For Finding Meaning in Cancer: A Longitudinal Study Dissertation zur

More information

Opioid Rotation. Dr Bruno Gagnon, M.D., M.Sc.

Opioid Rotation. Dr Bruno Gagnon, M.D., M.Sc. Opioid Rotation Dr Bruno Gagnon, M.D., M.Sc. Associate Professor Department of Family Medicine and Emergency Medicine, Faculty of Medicine, Université Laval Consultant in Palliative Medicine CHU de Québec-Université

More information

Breakthrough Pain in Oncology: A Longitudinal Study

Breakthrough Pain in Oncology: A Longitudinal Study Vol. 40 No. 2 August 2010 Journal of Pain and Symptom Management 183 Original Article Breakthrough Pain in Oncology: A Longitudinal Study Sebastiano Mercadante, MD, Vittoria Zagonel, MD, Enrico Breda,

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Malignant melanoma: assessment and management of malignant melanoma 1.1 Short title Malignant Melanoma 2 The remit The Department

More information

Dose titration of sublingual fentanyl, in relation to transdermal fentanyl dosing in cancer patients

Dose titration of sublingual fentanyl, in relation to transdermal fentanyl dosing in cancer patients 74 Dose titration of sublingual fentanyl, in relation to transdermal fentanyl dosing in cancer patients Amaniti E MD, PhD, Zaralidou A MD, Maidatsi P MD, PhD, Mitos G MD, Thoma G MD, Vasilakos D MD, PhD.

More information

Report on Cancer Statistics in Alberta. Kidney Cancer

Report on Cancer Statistics in Alberta. Kidney Cancer Report on Cancer Statistics in Alberta Kidney Cancer November 29 Surveillance - Cancer Bureau Health Promotion, Disease and Injury Prevention Report on Cancer Statistics in Alberta - 2 Purpose of the Report

More information

Update on Sentinel Node Biopsy in Endometrial Cancer: Feasibility, Technique, Impact

Update on Sentinel Node Biopsy in Endometrial Cancer: Feasibility, Technique, Impact Update on Sentinel Node Biopsy in Endometrial Cancer: Feasibility, Technique, Impact Bjørn Hagen, MD, PhD St Olavs Hospital Trondheim University Hospital Trondheim, Norway Endometrial Cancer (EC) The most

More information

Introduction to REMARK: Reporting tumour marker prognostic studies

Introduction to REMARK: Reporting tumour marker prognostic studies Introduction to REMARK: Reporting tumour marker prognostic studies Doug Altman The EQUATOR Network Centre for Statistics in Medicine, Oxford, UK C 1 S M Reliable research Reliability is determined by proper

More information

Sprays for pain management as an alternative to injection and other routes of administration

Sprays for pain management as an alternative to injection and other routes of administration Prescription Division Sprays for pain management as an alternative to injection and other routes of administration A scientific roundtable hosted by Aptar Pharma Prescription Division Delivering solutions,

More information

Report on Cancer Statistics in Alberta. Melanoma of the Skin

Report on Cancer Statistics in Alberta. Melanoma of the Skin Report on Cancer Statistics in Alberta Melanoma of the Skin November 29 Surveillance - Cancer Bureau Health Promotion, Disease and Injury Prevention Report on Cancer Statistics in Alberta - 2 Purpose of

More information

Addressing Mental Health in HIV Prevention and Treatment Research Kathleen J. Sikkema, Ph.D.

Addressing Mental Health in HIV Prevention and Treatment Research Kathleen J. Sikkema, Ph.D. Addressing Mental Health in HIV Prevention and Treatment Research Kathleen J. Sikkema, Ph.D. Professor of Psychology and Neuroscience, Global Health, and Psychiatry and Behavioral Sciences Director, Social

More information

Foundations of Palliative Care Series

Foundations of Palliative Care Series Foundations of Palliative Care Series Developed by: Tim Sakaluk MD, Ingrid See CPL, Tammy Dyson SW, Sharon Salomons SCP!!!!!! This course was developed in collaboration with the UBC Learning Circle to

More information

The Edmonton Symptom Assessment System (ESAS) poor performance as screener for major depression in patients with incurable cancer

The Edmonton Symptom Assessment System (ESAS) poor performance as screener for major depression in patients with incurable cancer 1 The Edmonton Symptom Assessment System (ESAS) poor performance as screener for major depression in patients with incurable cancer Elisabeth Brenne 1,2, Jon H Loge 1,4,5, Hanne Lie 3,4, Marianne J Hjermstad

More information

Acute pain management in opioid tolerant patients. Muhammad Laklouk

Acute pain management in opioid tolerant patients. Muhammad Laklouk Acute pain management in opioid tolerant patients Muhammad Laklouk General principles An adequate review and assessment Provision of effective analgesia (including attenuation of tolerance and hyperalgesia)

More information

Revisit of Primary Malignant Neoplasms of the Trachea: Clinical Characteristics and Survival Analysis

Revisit of Primary Malignant Neoplasms of the Trachea: Clinical Characteristics and Survival Analysis Jpn J Clin Oncol 1997;27(5)305 309 Revisit of Primary Malignant Neoplasms of the Trachea: Clinical Characteristics and Survival Analysis -, -, - - 1 Chest Department and 2 Section of Thoracic Surgery,

More information

Breathlessness in advanced disease. February 2017

Breathlessness in advanced disease. February 2017 Breathlessness in advanced disease February 2017 Breathlessness Managing breathlessness in primary care Chronic breathlessness Acute exacerbation of breathlessness Breathlessness at end of life Breathlessness

More information

Assessing older patients with hematological malignancies

Assessing older patients with hematological malignancies Assessing older patients with hematological malignancies Alfonso J. Cruz Jentoft Servicio de Geriatría Hospital Universitario Ramón y Cajal Madrid, Spain Is old = frail? 45 days old 2,000 years old 4,600

More information

Disclosures. Ms. Walsh has nothing to disclose Ms. Broglio is on the speaker s bureau for Genentech and Meda Pharmaceuticals

Disclosures. Ms. Walsh has nothing to disclose Ms. Broglio is on the speaker s bureau for Genentech and Meda Pharmaceuticals Anne F. Walsh, MSN, ANP BC, ACHPN, CWOCN Kathleen Broglio, MN, ANP BC, ACHPN, CPE Disclosures Ms. Walsh has nothing to disclose Ms. Broglio is on the speaker s bureau for Genentech and Meda Pharmaceuticals

More information

NATIONAL BOWEL CANCER AUDIT The feasibility of reporting Patient Reported Outcome Measures as part of a national colorectal cancer audit

NATIONAL BOWEL CANCER AUDIT The feasibility of reporting Patient Reported Outcome Measures as part of a national colorectal cancer audit NATIONAL BOWEL CANCER AUDIT The feasibility of reporting Patient Reported Outcome Measures as part of a national colorectal cancer audit NBOCA: Feasibility Study Date of publication: Thursday 9 th August

More information

Terminating active cancer treatment clinical and ethical perspectives

Terminating active cancer treatment clinical and ethical perspectives Heidelberg, 19th Sept. 2014 Terminating active cancer treatment clinical and ethical perspectives Eva Winkler NCT-EPOC Programme for Ethics and Patient-Oriented Care in Oncology Overview 1. Current practice

More information

Open Access Screening for Cancer-Related Neuropathic Pain in the Oncology Outpatient Setting in the United Kingdom

Open Access Screening for Cancer-Related Neuropathic Pain in the Oncology Outpatient Setting in the United Kingdom Send Orders for Reprints to reprints@benthamscience.net 208 The Open Pain Journal, 2013, 6, 208-216 Open Access Screening for Cancer-Related Neuropathic Pain in the Oncology Outpatient Setting in the United

More information

Appendix F- Edmonton Symptom Assessment System (ESAS), Canadian Problem Checklist, and Distress Thermometer for Cancer Patients

Appendix F- Edmonton Symptom Assessment System (ESAS), Canadian Problem Checklist, and Distress Thermometer for Cancer Patients Appendix F- Edmonton Symptom Assessment System (ESAS), Canadian Problem Checklist, and Distress Thermometer for Cancer Patients Screening Cancer Patients for Distress in Nova Scotia with the ESAS, CPC,

More information

Cancer pain (i.e., pain associated with cancer or

Cancer pain (i.e., pain associated with cancer or PAIN MEDICINE Volume 10 Number 3 2009 PALLIATIVE CARE SECTION Original Research Article Cancer and Breakthrough Pain s Impact on a Diverse Population Laura Montague, BS,* and Carmen R. Green, MD*, *Department

More information

Breast Cancer Staging

Breast Cancer Staging Breast Cancer Staging Symposium on Best Practice in Recording Cancer Stage Royal College of Pathologists 10 June 2011 Dr Gill Lawrence, Director Tel: 0121 415 8129 Fax: 0121 414 7712 Email: gill.lawrence@wmciu.nhs.uk

More information

Gastrointestinal Neuroendocrine Tumors: A Closer Look at the Characteristics of These Diverse Tumors

Gastrointestinal Neuroendocrine Tumors: A Closer Look at the Characteristics of These Diverse Tumors Gastrointestinal Neuroendocrine Tumors: A Closer Look at the Characteristics of These Diverse Tumors Jaume Capdevila, MD, PhD Vall d'hebron University Hospital Vall d'hebron Institute of Oncology (VHIO)

More information

Prognostic factors in squamous cell anal cancers

Prognostic factors in squamous cell anal cancers Prognostic factors in squamous cell anal cancers Zainul Abedin Kapacee Year 4-5 Intercalating Medical Student, University of Manchester Dr. Shabbir Susnerwala, Mr. Nigel Scott Dr. Falalu Danwata, Dr. Marcus

More information